Related Experiment Videos
Equine viral arteritis
1Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center, Kennett Square 19348-1692, USA. fdp@vet.upenn.edu
Veterinary Pathology
|July 15, 2000
Summary
Equine viral arteritis (EVA), caused by equine arteritis virus (EAV), impacts the equine industry economically. This review details EVA
Area of Science:
- Veterinary Pathology
- Virology
- Equine Medicine
Background:
- Equine viral arteritis (EVA) poses significant economic threats to the equine industry.
- EVA is caused by the equine arteritis virus (EAV), targeting the vascular system primarily.
- The virus exhibits diverse clinical presentations and pathological findings.
Purpose of the Study:
- To familiarize pathologists with the clinical aspects, lesions, pathogenesis, and diagnostic methods for EVA.
- To provide a comprehensive overview of EAV infection in horses.
Main Methods:
- Review of existing literature on Equine Viral Arteritis.
- Pathological examination and immunohistochemistry for EAV antigen detection.
- Virus isolation and serological testing for diagnostic confirmation.
Main Results:
- EAV targets various cell types, including epithelial cells, endothelial cells, myocytes, and macrophages.
- Systemic spread involves monocytes, leading to vascular, renal, and reproductive system involvement.
- Lesions in aborted fetuses are typically mild and EAV antigen may be undetectable.
Conclusions:
- EVA presents with variable clinical signs and lesions that can mimic other equine diseases.
- Accurate diagnosis requires thorough pathological examination, immunohistochemistry, virus isolation, and serology.
- Early and correct diagnosis is crucial for managing EVA outbreaks and economic impact.